The next controversy in genetic testing: clinical data as trade secrets?

Abstract excerpt

Sole-source business models for genetic testing can create private databases containing information vital to interpreting the clinical significance of human genetic variations. But incomplete access to those databases threatens to impede the clinical interpretation of genomic medicine. National health systems and insurers, regulators, researchers, providers and patients all have a strong interest in ensuring...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Confidentiality
• Share to Genetic Testing
• Share to Genetic Variation